{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:58:50Z","timestamp":1791136730210,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1097\/shk.0b013e318033e5da","type":"journal-article","created":{"date-parts":[[2007,5,18]],"date-time":"2007-05-18T21:52:01Z","timestamp":1179525121000},"page":"219-226","source":"Crossref","is-referenced-by-count":219,"title":["COPEPTIN, A STABLE PEPTIDE OF THE ARGININE VASOPRESSIN PRECURSOR, IS ELEVATED IN HEMORRHAGIC AND SEPTIC SHOCK"],"prefix":"10.1097","volume":"28","author":[{"given":"Nils G.","family":"Morgenthaler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Struck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Redl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Christ-Crain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210213","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure.","volume":"341","author":"Schrier","year":"1999","journal-title":"N Engl J Med"},{"key":"R3-15-20210213","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00003495-200363030-00001","article-title":"Management of vasodilatory shock: defining the role of arginine vasopressin.","volume":"63","author":"Dunser","year":"2003","journal-title":"Drugs"},{"key":"R4-15-20210213","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1742-1241.2002.tb11375.x","article-title":"The physiology and emerging roles of antidiuretic hormone.","volume":"56","author":"Singh Ranger","year":"2002","journal-title":"Int J Clin Pract"},{"key":"R5-15-20210213","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2005.02.095","article-title":"Vasopressin antagonism in heart failure.","volume":"46","author":"Goldsmith","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R6-15-20210213","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00000542-199210000-00008","article-title":"Stress hormone response during and after cardiopulmonary resuscitation.","volume":"77","author":"Lindner","year":"1992","journal-title":"Anesthesiology"},{"key":"R7-15-20210213","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.CCM.0000134267.91520.C0","article-title":"Vasopressin during cardiopulmonary resuscitation: a progress report.","volume":"32","author":"Krismer","year":"2004","journal-title":"Crit Care Med"},{"key":"R8-15-20210213","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00134-004-2283-8","article-title":"Role of vasopressin in the management of septic shock.","volume":"30","author":"Mutlu","year":"2004","journal-title":"Intensive Care Med"},{"key":"R9-15-20210213","doi-asserted-by":"crossref","first-page":"I129","DOI":"10.1161\/01.HYP.5.2_Pt_2.I129","article-title":"Plasma and platelet vasopressin in essential hypertension and congestive heart failure.","volume":"5","author":"Preibisz","year":"1983","journal-title":"Hypertension"},{"key":"R10-15-20210213","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/clinchem\/45.1.98","article-title":"Improved extraction procedure and RIA for determination of arginine8-vasopressin in plasma: role of premeasurement sample treatment and reference values in children.","volume":"45","author":"Kluge","year":"1999","journal-title":"Clin Chem"},{"key":"R11-15-20210213","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1172\/JCI107423","article-title":"Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma.","volume":"52","author":"Robertson","year":"1973","journal-title":"J Clin Invest"},{"key":"R12-15-20210213","first-page":"368","article-title":"The use of vasopressin assays in physiology and pathophysiology.","volume":"14","author":"Robertson","year":"1994","journal-title":"Semin Nephrol"},{"key":"R13-15-20210213","first-page":"384","article-title":"Vasopressin in pathophysiological states.","volume":"14","author":"Gines","year":"1994","journal-title":"Semin Nephrol"},{"key":"R14-15-20210213","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/295299a0","article-title":"Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor.","volume":"295","author":"Land","year":"1982","journal-title":"Nature"},{"key":"R15-15-20210213","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1432-1033.1972.tb01918.x","article-title":"A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization.","volume":"28","author":"Holwerda","year":"1972","journal-title":"Eur J Biochem"},{"key":"R17-15-20210213","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1021\/bi0400094","article-title":"Properties of human vasopressin precursor constructs: inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus.","volume":"43","author":"Barat","year":"2004","journal-title":"Biochemistry"},{"key":"R18-15-20210213","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.peptides.2005.04.019","article-title":"Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients.","volume":"26","author":"Struck","year":"2005","journal-title":"Peptides"},{"key":"R19-15-20210213","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin.","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"R20-15-20210213","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00586258","article-title":"The effects of hypotension and hypovolaemia on the liberation of vasopressin during haemorrhage in the unanaesthetized monkey (Macaca mulatta).","volume":"371","author":"Arnauld","year":"1977","journal-title":"Pflugers Arch"},{"key":"R21-15-20210213","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock.","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"},{"key":"R22-15-20210213","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","article-title":"Circulating vasopressin levels in septic shock.","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit Care Med"},{"key":"R23-15-20210213","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.CCM.0000198528.56397.4F","article-title":": Serum vasopressin concentrations in critically ill patients.","volume":"34","author":"Jochberger","year":"2006","journal-title":"Crit Care Med"},{"key":"R24-15-20210213","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00003246-200004000-00011","article-title":"Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.","volume":"28","author":"Muller","year":"2000","journal-title":"Crit Care Med"},{"key":"R25-15-20210213","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1365-2362.2000.00714.x","article-title":": Disordered calcium homeostasis of sepsis: association with calcitonin precursors.","volume":"30","author":"Muller","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"R26-15-20210213","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/cc3015","article-title":"Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study.","volume":"9","author":"Morgenthaler","year":"2005","journal-title":"Crit Care"},{"key":"R27-15-20210213","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.","volume":"20","year":"1992","journal-title":"Crit Care Med"},{"key":"R28-15-20210213","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-9149(01)02166-X","article-title":"Usefulness of plasma N-terminal proatrial natriuretic peptide (proANP) as an early predictor of outcome in unstable angina pectoris or non-ST-elevation acute myocardial infarction.","volume":"89","author":"Jernberg","year":"2002","journal-title":"Am J Cardiol"},{"key":"R29-15-20210213","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2003-0006","article-title":"Cardiac hormones as diagnostic tools in heart failure.","volume":"24","author":"Ruskoaho","year":"2003","journal-title":"Endocr Rev"},{"key":"R30-15-20210213","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1373\/clinchem.2003.021204","article-title":"Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma.","volume":"50","author":"Morgenthaler","year":"2004","journal-title":"Clin Chem"},{"key":"R31-15-20210213","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1373\/clinchem.2005.051110","article-title":"Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.","volume":"51","author":"Morgenthaler","year":"2005","journal-title":"Clin Chem"},{"key":"R32-15-20210213","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1373\/clinchem.2005.065581","article-title":"Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma.","volume":"52","author":"Papassotiriou","year":"2006","journal-title":"Clin Chem"},{"key":"R33-15-20210213","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0006-291X(90)91216-F","article-title":"Isolation and functional expression of the human atrial natriuretic peptide clearance receptor cDNA.","volume":"171","author":"Porter","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"R34-15-20210213","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"R35-15-20210213","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-003-1662-x","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference.","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med"},{"key":"R36-15-20210213","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.CCM.0000199074.72478.8B","article-title":"Are vasopressin levels increased or decreased in septic shock?","volume":"34","author":"Sutherland","year":"2006","journal-title":"Crit Care Med"},{"key":"R37-15-20210213","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock.","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"key":"R38-15-20210213","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.","volume":"107","author":"Dunser","year":"2003","journal-title":"Circulation"},{"key":"R39-15-20210213","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00003246-200203000-00036","article-title":"Endocrine support in the critically ill.","volume":"30","author":"Vincent","year":"2002","journal-title":"Crit Care Med"},{"key":"R40-15-20210213","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1592\/phco.24.11.1050.36144","article-title":"The role of vasopressin in vasodilatory septic shock.","volume":"24","author":"Obritsch","year":"2004","journal-title":"Pharmacotherapy"},{"key":"R41-15-20210213","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/cc2945","article-title":"Clinical review: vasopressin and terlipressin in septic shock patients.","volume":"9","author":"Delmas","year":"2005","journal-title":"Crit Care"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00024382-200708000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T12:36:48Z","timestamp":1737031008000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00024382-200708000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e318033e5da","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}